388 related articles for article (PubMed ID: 9415314)
21. Identical defects in DNA repair in xeroderma pigmentosum group G and rodent ERCC group 5.
O'Donovan A; Wood RD
Nature; 1993 May; 363(6425):185-8. PubMed ID: 8483505
[TBL] [Abstract][Full Text] [Related]
22. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
23. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
[TBL] [Abstract][Full Text] [Related]
24. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
[TBL] [Abstract][Full Text] [Related]
25. Recovery of normal DNA repair and mutagenesis in trichothiodystrophy cells after transduction of the XPD human gene.
Marionnet C; Quilliet X; Benoit A; Armier J; Sarasin A; Stary A
Cancer Res; 1996 Dec; 56(23):5450-6. PubMed ID: 8968100
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of p53 enhances transcription-coupled repair and global genomic repair of a UVC-damaged reporter gene in human cells.
Dregoesc D; Rybak AP; Rainbow AJ
DNA Repair (Amst); 2007 May; 6(5):588-601. PubMed ID: 17196445
[TBL] [Abstract][Full Text] [Related]
27. [Progress of research on xeroderma pigmentosum].
Tanaka K
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1095-103. PubMed ID: 2190536
[TBL] [Abstract][Full Text] [Related]
28. [DNA repair defect in xeroderma pigmentosum].
Tanaka K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):473-80. PubMed ID: 2650628
[TBL] [Abstract][Full Text] [Related]
29. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
30. Mutations in XPB and XPD helicases found in xeroderma pigmentosum patients impair the transcription function of TFIIH.
Coin F; Bergmann E; Tremeau-Bravard A; Egly JM
EMBO J; 1999 Mar; 18(5):1357-66. PubMed ID: 10064601
[TBL] [Abstract][Full Text] [Related]
31. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
32. Xeroderma pigmentosum genes: functions inside and outside DNA repair.
Sugasawa K
Carcinogenesis; 2008 Mar; 29(3):455-65. PubMed ID: 18174245
[TBL] [Abstract][Full Text] [Related]
33. Complementation of the DNA repair defect in xeroderma pigmentosum group G cells by a human cDNA related to yeast RAD2.
Scherly D; Nouspikel T; Corlet J; Ucla C; Bairoch A; Clarkson SG
Nature; 1993 May; 363(6425):182-5. PubMed ID: 8483504
[TBL] [Abstract][Full Text] [Related]
34. Long-term complementation of DNA repair deficient human primary fibroblasts by retroviral transduction of the XPD gene.
Quilliet X; Chevallier-Lagente O; Eveno E; Stojkovic T; Destée A; Sarasin A; Mezzina M
Mutat Res; 1996 Dec; 364(3):161-9. PubMed ID: 8960128
[TBL] [Abstract][Full Text] [Related]
35. Mutations in the XPD gene leading to xeroderma pigmentosum symptoms.
Kobayashi T; Kuraoka I; Saijo M; Nakatsu Y; Tanaka A; Someda Y; Fukuro S; Tanaka K
Hum Mutat; 1997; 9(4):322-31. PubMed ID: 9101292
[TBL] [Abstract][Full Text] [Related]
36. Effects of XPD mutations on ultraviolet-induced apoptosis in relation to skin cancer-proneness in repair-deficient syndromes.
Queille S; Drougard C; Sarasin A; Daya-Grosjean L
J Invest Dermatol; 2001 Nov; 117(5):1162-70. PubMed ID: 11710928
[TBL] [Abstract][Full Text] [Related]
37. A novel XPC pathogenic variant detected in archival material from a patient diagnosed with Xeroderma Pigmentosum: a case report and review of the genetic variants reported in XPC.
Rivera-Begeman A; McDaniel LD; Schultz RA; Friedberg EC
DNA Repair (Amst); 2007 Jan; 6(1):100-14. PubMed ID: 17079196
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
39. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
[TBL] [Abstract][Full Text] [Related]
40. Development of new EBV-based vectors for stable expression of small interfering RNA to mimick human syndromes: application to NER gene silencing.
Biard DS; Despras E; Sarasin A; Angulo JF
Mol Cancer Res; 2005 Sep; 3(9):519-29. PubMed ID: 16179499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
